The primary clinical trials for tirzepatide (SURMOUNT-1 through SURMOUNT-4) focused on weight loss efficacy and cardiometabolic outcomes, not reproductive endpoints
Although absorption of each component of the mixture fit the zero-order release model (table S2), neither GLP1-ELP nor ELP-FGF21 maintained steady plasma levels for as long as GLP1-ELP-FGF21 did, suggesting a pharmacokinetic advantage to delivering the two drugs in a unimolecular format
Reduced glucose uptake by peripheral tissues in turn leads to a reduced rate of glucose metabolism
For at-home use following minor injuries, irritation, or inflammation, copper peptide serums can accelerate healing while preventing potential scarring
Notably, exogenous GSH significantly increased Hg tolerance
Cell membrane inspired nano-shell enabling long-acting glucose oxidase for melanoma starvation therapy via microneedles-based percutaneous delivery